In addition, these antiviral drugs have little impact on the spread of HSV-2 infection with 10 to 20 million per year continuing to acquire new infections. Research is underway to produce more effective methods to control HSV-2 infections such as vaccines of topical microbicides, but to date none are readily available for public use (Johnston et al., 2011; Nikolic and Piguet, 2010) . epithelial skin cells fluctuates with the host cell circadian (molecular) clock. Variable expression over time of Nectin-1 results in an enhanced uptake of HSV-2 during the "active phase" in a murine model, which further results in increased viral titer, cytokine expression, and HSV-2 pathology.
Studies have to date linked numerous molecular processes within cells to the coordinated oscillations of the circadian clock (24-hour cycle), and this connection has become an ever increasing field of interest in disease regulation. The body's internal clock is located in the hypothalamic suprachiasmatic nuclei. From here, neural and humoral signals regulate output pathways that control internal temperature, hormone regulation, metabolism, and cell cycle.
On a molecular level, the circadian clock controls an independent transcription translation feedback loop including a negative feedback loop involving the genes Clock, Bmal1, Period1 Matsuzawa et al now demonstrate that HSV-2 pathology, viral titer, and innate immune responses varied depending on the time at which the mice were infected, with mice showing more severe infection at the active phase (ZT18/night) in comparison to the rest phase (ZT6/day). Similar observations were made in RAG-2-deficient mice, suggesting that acquired immunity did not influence the differential infection levels observed, which agrees with previous studies. The authors went on to demonstrate that expression of the HSV-2 receptor Nectin1 (Pvrl1) is upregulated during the active phase in correlation to increased viral pathology and titer observed. Expression levels of Pvrl1 were found to fluctuate over time, and the authors demonstrated that Nectin-1 expression was under the direct regulation of the Clock gene and therefore the host circadian clock (see Figure 1) . Furthermore, and adding some clinical relevance to their findings, they also show that a larger dose of acyclovir is necessary to treat HSV-2 acquired in the active phase compared with the lower dose required to control infection acquired during the rest phase (Matsuzawa et al 2017) .
In light of these studies, it would be of interest to see if changes in circadian gene expression and resulting effects on the host cells can also influence viral transmission to naıve hosts. For example, could fluctuating expression levels of viral genes influence the rate of transmission between hosts in a time dependent manner? However, as with all complex pathways, it should also be kept in mind that Clock genes control multiple host cellular pathways influencing the immune response and cell metabolism to name a few. In addition, research in this field will no doubt be of importance for novel therapeutic strategies looking into how the circadian clock may influence the administration of drugs, such as time of treatment. Finally, identification of circadian genes involved in viral propagation could be used as targets for antiviral therapies and help develop other novel strategies for disease prevention. Pvrl1 expression is under the control of the circadian CLOCK in murine keratinocytes resulting in increased HSV-2 pathology at the active phase. The host circadian clock controls a transcription-translation feedback loop involving the genes CLOCK/NPAS2, Bmal1, Period1 (Per1), Per2 and Cryptochrome1 (Cry1) and Cry2. CLOCK: BMAL1 activate transcription of the Per1/2 and Cry1/2 genes. The PER and CRY proteins go on to heterodimerise resulting in translocation to the nucleus where they inhibit their own transcription by interacting with CLOCK:BMAL1 over a 24 hour period. Wild-type mice were intradermally infected with HSV-2 at ZT6 'rest phase' (ZT6) or 'active phase' (ZT18). CLOCK was found to bind to an E-box-like region present in the promoter region of the gene Prvl1 causing an increase in expression levels of the HSV-2 receptor Nectin-1 in the active phase which correlated to an observed increase in pathology and viral titre in comparison to mice infected at rest phase (ZT6).
